Trial Condition(s):

Bone Neoplasms

Bonefos and the consumption of analgesics (BICAM)

Bayer Identifier:

14236

ClinicalTrials.gov Identifier:

NCT00909142

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The effect of Bonefos on consumption of analgesics (drugs used for pain treatment) in patients with proven bone metastases.

Inclusion Criteria
- Breast cancer or prostate cancer or multiple myeloma. 
 - Bone metastasis. 
 - Ability to use analgesics and clodronate 1600 mg/day.
Exclusion Criteria
- Hypersensitivity to bisphosphonates. 
 - Clodronate in previous therapy. 
 - Concomitant use of other bisphosphonates. 
 - Serious renal insufficiency.

Trial Summary

Enrollment Goal
149
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Bonefos (Clodronate, BAY94-8393)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Czech Republic

Status
Completed
 

Trial Design